Search details
1.
Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives.
Mol Psychiatry
; 29(3): 847-857, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38228892
2.
Evidence for reduced anti-inflammatory microglial phagocytic response in late-life major depression.
Brain Behav Immun
; 120: 248-255, 2024 May 23.
Article
in English
| MEDLINE | ID: mdl-38795783
3.
Role of monomeric amyloid-ß in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies.
Pharmacol Res
; 187: 106631, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36586644
4.
Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease.
Alzheimers Dement
; 19(10): 4729-4734, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37079778
5.
A critical appraisal of tau-targeting therapies for primary and secondary tauopathies.
Alzheimers Dement
; 18(5): 1008-1037, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34533272
6.
Lecanemab in Early Alzheimer's Disease.
N Engl J Med
; 388(17): 1630-1631, 2023 Apr 27.
Article
in English
| MEDLINE | ID: mdl-37099353
7.
Amyloid-ß immunotherapy for alzheimer disease: Is it now a long shot?
Ann Neurol
; 85(3): 303-315, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30635926
8.
Time to test antibacterial therapy in Alzheimer's disease.
Brain
; 142(10): 2905-2929, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-31532495
9.
Structure-activity relationships of flurbiprofen analogues as stabilizers of the amyloidogenic protein transthyretin.
J Struct Biol
; 208(2): 165-173, 2019 11 01.
Article
in English
| MEDLINE | ID: mdl-31473362
10.
Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci.
Lab Invest
; 98(4): 512-524, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29330472
11.
Should we lower or raise levels of amyloid-ß in the brains of Alzheimer patients?
Pharmacol Res
; 183: 106390, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35940397
12.
Emerging drugs to reduce abnormal ß-amyloid protein in Alzheimer's disease patients.
Expert Opin Emerg Drugs
; 21(4): 377-391, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27678025
13.
Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-ß42.
J Alzheimers Dis
; 99(3): 877-881, 2024.
Article
in English
| MEDLINE | ID: mdl-38701151
14.
A critical appraisal of blood-based biomarkers for Alzheimer's disease.
Ageing Res Rev
; 96: 102290, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38580173
15.
Receptor for advanced glycation end products contributes to postnatal pulmonary development and adult lung maintenance program in mice.
Am J Respir Cell Mol Biol
; 48(2): 164-71, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23144333
16.
CHF5074 restores visual memory ability and pre-synaptic cortical acetylcholine release in pre-plaque Tg2576 mice.
J Neurochem
; 124(5): 613-20, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23278303
17.
Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.
BMC Neurosci
; 14: 44, 2013 Apr 05.
Article
in English
| MEDLINE | ID: mdl-23560952
18.
Pharmacokinetics and pharmacodynamics of CHF5074 after short-term administration in healthy subjects.
Alzheimer Dis Assoc Disord
; 27(3): 278-86, 2013.
Article
in English
| MEDLINE | ID: mdl-22922591
19.
Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging.
Alzheimers Dement
; 9(2): 113-22, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23245560
20.
Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trials.
Neural Regen Res
; 18(8): 1679-1683, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36751779